We exist to improve the lives
of everyone affected by epilepsy

Epilepsy with myoclonic absences

What is a syndrome?

A syndrome is a group of signs and symptoms that, added together, suggest a particular medical condition. In epilepsy, examples of these signs and symptoms would be things like the age at which seizures begin, the type of seizures, whether the child is male or female and whether they have physical or learning disabilities, or both. The results of an electroencephalogram (EEG) are also used to help identify epilepsy syndromes.

Epilepsy Action has more information about seizure types, learning disabilities, and the EEG.

If you would like to know more about an epilepsy syndrome, please speak to your doctor. If you would like to know more about epilepsy in general, please contact Epilepsy Action.

Epilepsy with myoclonic absences

Epilepsy with myoclonic absences is a rare form of epilepsy. It happens more in boys than girls, and approximately 25 out of every 100 children (one quarter) will have another family member with a form of epilepsy. The underlying cause of this epilepsy syndrome is unknown. Myoclonic absences may be seen in children with brain abnormalities or with some genetic disorders.

Symptoms

The child loses awareness of their surroundings. How much their awareness is changed will vary from child to child. This is accompanied by severe rhythmical jerking of both upper limbs (possibly one arm more than the other). There can often be a stiffening of the upper arms resulting in the arms being raised upwards. Sometimes jerking of the muscles around the chin and mouth, but not the eyes, may also happen. The seizure usually lasts for eight to 60 seconds. Seizures are more common when the child is tired or has just woken up.

Other seizure types such as tonic-clonic, drop attacks and typical absence seizures can happen in about two-thirds of children. Almost half of all children with epilepsy with myoclonic absences have some degree of learning disability before the start of their seizures. Of the remainder, a further half will develop learning disabilities and behavioural problems after their seizures start.

Diagnosis

A description of the seizure given by the child and any eyewitnesses can help with identifying the particular seizure type in this epilepsy syndrome. An EEG will be carried out. The doctor may try to provoke a seizure by getting the child to hyperventilate (over-breathe) for up to four minutes. Although this may feel unpleasant, it is important in order to correctly diagnose this syndrome. The doctor may want to order further tests, including a brain scan and a blood test, to look for genetic disorders.

Epilepsy Action has more information about diagnosing epilepsy.

Treatment

Treatment is often difficult, as seizures may not respond to epilepsy medicines. Commonly used epilepsy medicines include sodium valproate (Epilim), ethosuximide (Zarontin) and lamotrigine (Lamictal). A combination of lamotrigine and sodium valproate, or ethosuximide and sodium valproate, is often more effective than a single drug. Another epilepsy medicine, clobazam (Frisium) may also be helpful.

Epilepsy Action has more information on the treatment of epilepsy.

Prognosis (outlook)

Epilepsy with myoclonic absences has a variable but often poor prognosis, with over half of all children continuing to have seizures into adulthood. Children whose seizures don’t respond well to treatment are at particular risk of developing other seizure types. There is some evidence that these children are also most at risk of developing learning and behavioural difficulties.


Advice and support organisations

Contact a Family

Freephone helpline (UK only): 0808 808 3555
Website: cafamily.org.uk
Email: info@cafamily.org.uk

Pay it forward

This resource is freely available as part of Epilepsy Action’s commitment to improving life for all those affected by epilepsy.

On average it costs £414 to produce an advice and information page – if you have valued using this resource, please text FUTURE to 70500 to donate £3 towards the cost of our future work. Terms and conditions. Thank you

Code: 
S023.02

Our thanks

Epilepsy Action would like to thank:

  • Dr Richard Appleton, and Dr Rachel Kneen, consultant paediatric neurologists at Alder Hey Children’s Hospital, Liverpool, UK and
  • Dr Stewart Macleod, consultant paediatric neurologist at Royal Hospital for Sick Children, Glasgow, UK.
    They have kindly prepared the information on this page. It is based on their own research, experience and expertise.

This information is exempt under the terms of The Information Standard.

  • Updated June 2012
    To be reviewed June 2015

There are no comments yet. Be the first to comment...

Contact Author

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
By submitting this form, you accept the Mollom privacy policy.